TY - JOUR
AU - Amy Board
AU - Denise V. D'Angelo
AU - Beatriz Salvesen von Essen
AU - Clark H. Denny
AU - Kathryn Miele
AU - Janae Dunkley
AU - Robert Baillieu
AU - Shin Y. Kim
A1 - 
AD - Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, US ocg3@cdc.gov; Division of Violence Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, US ; Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, US ; Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockville, MD, US ; Board, Amy,4770 Buford Highway, Mailstop S106-3,Atlanta,US,30341,Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention,ocg3@cdc.gov
BT - Drug and Alcohol Dependence
C5 - Opioids & Substance Use ; Healthcare Disparities
DB - APA PsycInfo®
DO - 10.1016/j.drugalcdep.2023.109872
JF - Drug and Alcohol Dependence
LA - English
PY - 2023
SN - 0376-8716, 0376-8716
SP - 1
EP - 8+
ST - Polysubstance use during pregnancy: The importance of screening, patient education, and integrating a harm reduction perspective
T1 - Polysubstance use during pregnancy: The importance of screening, patient education, and integrating a harm reduction perspective
T2 - Drug and Alcohol Dependence
TI - Polysubstance use during pregnancy: The importance of screening, patient education, and integrating a harm reduction perspective
U1 - Opioids & Substance Use ; Healthcare Disparities
U3 - 10.1016/j.drugalcdep.2023.109872
VL - 247
VO - 0376-8716, 0376-8716
Y1 - 2023
ER -